{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:55:49Z","timestamp":1787313349251,"version":"build-2736575974"},"reference-count":63,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alzheimer's disease (AD) is one of the most common diseases in\nthe elderly, with a high incidence of dementia. The pathogenesis of AD is complex, and\nthere is no unified conclusion and effective treatment in the clinic. In recent years, with\nthe development of traditional Chinese medicine (TCM), researchers put forward the idea\nof prevention and treatment of AD based on TCM according to the characteristics of multi-\ntarget of TCM. Ferulic acid (FA), also known as 3-methoxy-4-hydroxycinnamic acid, is\nan active ingredient in TCM that inhibits \u03b2-amyloid (A\u03b2) aggregation and has antioxidant\nand anti-inflammatory effects. FA derivatives have been reported to have low toxicity,\nhigh biological activity, and high blood-brain barrier permeability. However, the multitarget\nof FA in the treatment of AD has not been systematically elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>In this systematic review, we aimed to comprehensively assess the neuroprotective\neffects of FA and its derivatives on in vitro and in vivo AD models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched PubMed, Chinese National Knowledge Infrastructure (CNKI), Baidu\nAcademic, and Wanfang databases for relevant pre-clinical studies until November 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified studies that evaluated the efficacy of FA and its derivatives using\nrelevant keywords. 864 studies were included, of which 129 were found in PubMed, 111\nin CNKI, 454 in Baidu Academic, and 170 in Wanfang. Due to duplication between databases,\nand after applying the exclusion and inclusion criteria, 43 articles were selected.\nThereafter, the abstracts of the 43 articles were reviewed. Finally, 21 articles were included\nin this review, including 11 in vivo, 5 in vitro, and 5 in vivo and in vitro studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Previous studies have shown that FA or its derivatives have multiple therapeutic\neffects on AD models and can improve the symptoms of AD and resistance of AD\ncell models. FA and its derivatives have anti-A\u03b2 aggregation, antioxidant, antiinflammatory,\nand other effects and are potential drugs for the multi-targeted treatment of\nAD. The result of our study showed that FA and its derivatives have significant therapeutic\neffects on animal and cell models of AD, suggesting that they may be potential therapeutic\ndrugs for patients with AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867329666220906110506","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T05:15:30Z","timestamp":1662441330000},"page":"2796-2811","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuroprotective Properties of Ferulic Acid in Preclinical Models of\nAlzheimer\u2019s Disease: A Systematic Literature Review"],"prefix":"10.2174","volume":"30","author":[{"given":"Siyu","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-8037","authenticated-orcid":true,"given":"Xiaoyu","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"Lane C.A.","year":"2018","unstructured":"Lane C.A.; Hardy J.; Schott J.M.; Alzheimer\u2019s disease. Eur J Neurol 2018,25(1),59-70","journal-title":"Eur J Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11920-018-0978-8","volume":"20","author":"Wolinsky D.","year":"2018","unstructured":"Wolinsky D.; Drake K.; Bostwick J.; Diagnosis and management of neuropsychiatric symptoms in Alzheimer\u2019s Disease. Curr Psychiatry Rep 2018,20(12),117","journal-title":"Curr Psychiatry Rep"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"Braak H.","year":"1991","unstructured":"Braak H.; Braak E.; Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991,82(4),239-259","journal-title":"Acta Neuropathol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.2174\/1381612827666210612051713","volume":"27","author":"Rahman M.S.","year":"2021","unstructured":"Rahman M.S.; Uddin M.S.; Rahman M.A.; Samsuzzaman M.; Behl T.; Hafeez A.; Perveen A.; Barreto G.E.; Ashraf G.M.; Exploring the role of monoamine oxidase activity in aging and Alzheimer\u2019s disease. Curr Pharm Des 2021,27(38),4017-4029","journal-title":"Curr Pharm Des"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-981-32-9358-8_16","volume":"1184","author":"Gallardo G.","year":"2019","unstructured":"Gallardo G.; Holtzman D.M.; Amyloid-\u03b2 and Tau at the crossroads of Alzheimer\u2019s disease. Adv Exp Med Biol 2019,1184,187-203","journal-title":"Adv Exp Med Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","volume":"24","author":"Hung S.Y.","year":"2017","unstructured":"Hung S.Y.; Fu W.M.; Drug candidates in clinical trials for Alzheimer\u2019s disease. J Biomed Sci 2017,24(1),47","journal-title":"J Biomed Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12974-020-01918-x","volume":"17","author":"Liu G.J.","year":"2020","unstructured":"Liu G.J.; Tao T.; Wang H.; Zhou Y.; Gao X.; Gao Y.Y.; Hang C.H.; Li W.; Functions of resolvin D1-ALX\/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury. J Neuroinflammation 2020,17(1),239","journal-title":"J Neuroinflammation"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.3390\/molecules26175192","volume":"26","author":"Kim Y.","year":"2021","unstructured":"Kim Y.; Kim J.; He M.; Lee A.; Cho E.; Apigenin ameliorates scopolamine-induced cognitive dysfunction and neuronal damage in mice. Molecules 2021,26(17),5192","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-132690","volume":"41","author":"Tan C.C.","year":"2014","unstructured":"Tan C.C.; Yu J.T.; Wang H.F.; Tan M.S.; Meng X.F.; Wang C.; Jiang T.; Zhu X.C.; Tan L.; Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis. J Alzheimers Dis 2014,41(2),615-631","journal-title":"J Alzheimers Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","volume":"8","author":"Arndt J.W.","year":"2018","unstructured":"Arndt J.W.; Qian F.; Smith B.A.; Quan C.; Kilambi K.P.; Bush M.W.; Walz T.; Pepinsky R.B.; Bussi\u00e8re T.; Hamann S.; Cameron T.O.; Weinreb P.H.; Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2. Sci Rep 2018,8(1),6412","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","volume":"19","author":"Schneider L.","year":"2020","unstructured":"Schneider L.; A resurrection of aducanumab for Alzheimer\u2019s disease. Lancet Neurol 2020,19(2),111-112","journal-title":"Lancet Neurol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"Blennow K.","year":"2006","unstructured":"Blennow K.; de Leon M.J.; Zetterberg H.; Alzheimer\u2019s disease. Lancet 2006,368(9533),387-403","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/ijms20092313","volume":"20","author":"Andrade S.","year":"2019","unstructured":"Andrade S.; Ramalho M.J.; Loureiro J.A.; Pereira M.C.; Natural compounds for Alzheimer\u2019s disease therapy: A systematic review of preclinical and clinical studies. Int J Mol Sci 2019,20(9),2313","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1472-8206.2005.00332.x","volume":"19","author":"Srinivasan M.","year":"2005","unstructured":"Srinivasan M.; Rukkumani R.; Ram Sudheer A.; Menon V.P.; Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity. Fundam Clin Pharmacol 2005,19(4),491-496","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fct.2013.12.024","volume":"65","author":"Mancuso C.","year":"2014","unstructured":"Mancuso C.; Santangelo R.; Ferulic acid: Pharmacological and toxicological aspects. Food Chem Toxicol 2014,65,185-195","journal-title":"Food Chem Toxicol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","volume":"284","author":"Li D.","year":"2021","unstructured":"Li D.; Rui Y.; Guo S.; Luan F.; Liu R.; Zeng N.; Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives. Life Sci 2021,284,119921","journal-title":"Life Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"Hooijmans C.R.","year":"2014","unstructured":"Hooijmans C.R.; Rovers M.M.; de Vries R.B.M.; Leenaars M.; Ritskes-Hoitinga M.; Langendam M.W.; SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 2014,14(1),43","journal-title":"BMC Med Res Methodol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7874\/jao.2019.00248","volume":"24","author":"Kwak C.","year":"2020","unstructured":"Kwak C.; Han W.; Towards size of scene in auditory scene analysis: A systematic review. J Audiol Otol 2020,24(1),1-9","journal-title":"J Audiol Otol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s13311-021-01024-7","volume":"18","author":"Wang N.Y.","year":"2021","unstructured":"Wang N.Y.; Li J.N.; Liu W.L.; Huang Q.; Li W.X.; Tan Y.H.; Liu F.; Song Z.H.; Wang M.Y.; Xie N.; Mao R.R.; Gan P.; Ding Y.Q.; Zhang Z.; Shan B.C.; Chen L.D.; Zhou Q.X.; Xu L.; Ferulic acid ameliorates Alzheimer\u2019s Disease-like pathology and repairs cognitive decline by preventing capillary hypofunction in APP\/PS1 Mice. Neurotherapeutics 2021,18(2),1064-1080","journal-title":"Neurotherapeutics"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1142\/S0192415X15500214","volume":"43","author":"Tsai F.S.","year":"2015","unstructured":"Tsai F.S.; Wu L.Y.; Yang S.E.; Cheng H.Y.; Tsai C.C.; Wu C.R.; Lin L.W.; Ferulic acid reverses the cognitive dysfunction caused by amyloid \u03b2 peptide 1-40 through anti-oxidant activity and cholinergic activation in rats. Am J Chin Med 2015,43(2),319-335","journal-title":"Am J Chin Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2007.10.029","volume":"430","author":"Mamiya T.","year":"2008","unstructured":"Mamiya T.; Kise M.; Morikawa K.; Ferulic acid attenuated cognitive deficits and increase in carbonyl proteins induced by buthionine-sulfoximine in mice. Neurosci Lett 2008,430(2),115-118","journal-title":"Neurosci Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.pnpbp.2005.04.022","volume":"29","author":"Cho J.Y.","year":"2005","unstructured":"Cho J.Y.; Kim H.S.; Kim D.H.; Yan J.J.; Suh H.W.; Song D.K.; Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of \u03b2-amyloid peptide (1\u201342) in mice. Prog Neuropsychopharmacol Biol Psychiatry 2005,29(6),901-907","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"111808","DOI":"10.1016\/j.fct.2020.111808","volume":"146","author":"Wang N.","year":"2020","unstructured":"Wang N.; Zhou Y.; Zhao L.; Wang C.; Ma W.; Ge G.; Wang Y.; Ullah I.; Muhammad F.; Alwayli D.; Zhi D.; Li H.; Ferulic acid delayed amyloid \u03b2-induced pathological symptoms by autophagy pathway via a fasting-like effect in Caenorhabditis elegans. Food Chem Toxicol 2020,146,111808","journal-title":"Food Chem Toxicol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1248\/bpb.b12-00798","volume":"36","author":"Yan J.J.","year":"2013","unstructured":"Yan J.J.; Jung J.S.; Kim T.K.; Hasan M.A.; Hong C.W.; Nam J.S.; Song D.K.; Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol Pharm Bull 2013,36(1),140-143","journal-title":"Biol Pharm Bull"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.bjp.0704047","volume":"133","author":"Yan J.J.","year":"2001","unstructured":"Yan J.J.; Cho J.Y.; Kim H.S.; Kim K.L.; Jung J.S.; Huh S.O.; Suh H.W.; Kim Y.H.; Song D.K.; Protection against \u03b2-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 2001,133(1),89-96","journal-title":"Br J Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1471-4159.2004.02359.x","volume":"89","author":"Wenk G.L.","year":"2004","unstructured":"Wenk G.L.; McGann-Gramling K.; Hauss-Wegrzyniak B.; Ronchetti D.; Maucci R.; Rosi S.; Gasparini L.; Ongini E.; Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J Neurochem 2004,89(2),484-493","journal-title":"J Neurochem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2016.04.047","volume":"782","author":"Jung J.S.","year":"2016","unstructured":"Jung J.S.; Yan J.J.; Li H.M.; Sultan M.T.; Yu J.; Lee H.S.; Shin K.J.; Song D.K.; Protective effects of a dimeric derivative of ferulic acid in animal models of Alzheimer\u2019s disease. Eur J Pharmacol 2016,782,30-34","journal-title":"Eur J Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"112257","DOI":"10.1016\/j.ejmech.2020.112257","volume":"198","author":"Singh Y.P.","year":"2020","unstructured":"Singh Y.P.; Tej G.N.V.C.; Pandey A.; Priya K.; Pandey P.; Shankar G.; Nayak P.K.; Rai G.; Chittiboyina A.G.; Doerksen R.J.; Vishwakarma S.; Modi G.; Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer\u2019s disease. Eur J Med Chem 2020,198,112257","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1039\/D0FO00800A","volume":"11","author":"Wu Y.","year":"2020","unstructured":"Wu Y.; Shi Y.; Zheng X.; Dang Y.; Zhu C.; Zhang R.; Fu Y.; Zhou T.; Li J.; Lipophilic ferulic acid derivatives protect PC12 cells against oxidative damage via modulating \u03b2-amyloid aggregation and activating Nrf2 enzymes. Food Funct 2020,11(5),4707-4718","journal-title":"Food Funct"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JAD-130164","volume":"37","author":"Cui L.","year":"2013","unstructured":"Cui L.; Zhang Y.; Cao H.; Wang Y.; Teng T.; Ma G.; Li Y.; Li K.; Zhang Y.; Ferulic acid inhibits the transition of amyloid-\u03b242 monomers to oligomers but accelerates the transition from oligomers to fibrils. J Alzheimers Dis 2013,37(1),19-28","journal-title":"J Alzheimers Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fninf.2018.00031","volume":"12","author":"Meng G.","year":"2018","unstructured":"Meng G.; Meng X.; Ma X.; Zhang G.; Hu X.; Jin A.; Zhao Y.; Liu X.; Application of ferulic acid for Alzheimer\u2019s disease: Combination of text mining and experimental validation. Front Neuroinform 2018,12,31","journal-title":"Front Neuroinform"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1080\/09168451.2017.1336925","volume":"81","author":"Kikugawa M.","year":"2017","unstructured":"Kikugawa M.; Ida T.; Ihara H.; Sakamoto T.; Ferulic acid and its water-soluble derivatives inhibit nitric oxide production and inducible nitric oxide synthase expression in rat primary astrocytes. Biosci Biotechnol Biochem 2017,81(8),1607-1611","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"103413","DOI":"10.1016\/j.bioorg.2019.103413","volume":"94","author":"Lan J.S.","year":"2020","unstructured":"Lan J.S.; Zeng R.F.; Jiang X.Y.; Hou J.; Liu Y.; Hu Z.H.; Li H.X.; Li Y.; Xie S.S.; Ding Y.; Zhang T.; Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,94,103413","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/09168451.2015.1107463","volume":"80","author":"Kikugawa M.","year":"2016","unstructured":"Kikugawa M.; Tsutsuki H.; Ida T.; Nakajima H.; Ihara H.; Sakamoto T.; Water-soluble ferulic acid derivatives improve amyloid-\u03b2-induced neuronal cell death and dysmnesia through inhibition of amyloid-\u03b2 aggregation. Biosci Biotechnol Biochem 2016,80(3),547-553","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","volume":"130","author":"Sang Z.","year":"2017","unstructured":"Sang Z.; Pan W.; Wang K.; Ma Q.; Yu L.; Yang Y.; Bai P.; Leng C.; Xu Q.; Li X.; Tan Z.; Liu W.; Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2017,130,379-392","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"103506","DOI":"10.1016\/j.bioorg.2019.103506","volume":"95","author":"Tripathi A.","year":"2020","unstructured":"Tripathi A.; Choubey P.K.; Sharma P.; Seth A.; Saraf P.; Shrivastava S.K.; Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,95,103506","journal-title":"Bioorg Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","volume":"10","author":"Sang Z.","year":"2019","unstructured":"Sang Z.; Wang K.; Han X.; Cao M.; Tan Z.; Liu W.; Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci 2019,10(2),1008-1024","journal-title":"ACS Chem Neurosci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e55774","DOI":"10.1371\/journal.pone.0055774","volume":"8","author":"Mori T.","year":"2013","unstructured":"Mori T.; Koyama N.; Guillot-Sestier M.V.; Tan J.; Town T.; Ferulic acid is a nutraceutical \u03b2-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PLoS One 2013,8(2),e55774","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12640-018-9901-7","volume":"34","author":"Malikowska-Racia N.","year":"2018","unstructured":"Malikowska-Racia N.; Podkowa A.; Sa\u0142at K.; Phencyclidine and scopolamine for modeling amnesia in rodents: Direct comparison with the use of barnes maze test and contextual fear conditioning test in mice. Neurotox Res 2018,34(3),431-441","journal-title":"Neurotox Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.nlm.2013.09.013","volume":"106","author":"Lana D.","year":"2013","unstructured":"Lana D.; Cerbai F.; Di Russo J.; Boscaro F.; Giannetti A.; Petkova-Kirova P.; Pugliese A.M.; Giovannini M.G.; Hippocampal long term memory: Effect of the cholinergic system on local protein synthesis. Neurobiol Learn Mem 2013,106,246-257","journal-title":"Neurobiol Learn Mem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.taap.2016.11.008","volume":"314","author":"Cha Y.","year":"2017","unstructured":"Cha Y.; Lee S.H.; Jang S.K.; Guo H.; Ban Y.H.; Park D.; Jang G.Y.; Yeon S.; Lee J.Y.; Choi E.K.; Joo S.S.; Jeong H.S.; Kim Y.B.; A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene. Toxicol Appl Pharmacol 2017,314,48-54","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.brainresbull.2021.02.024","volume":"170","author":"Ahmadi N.","year":"2021","unstructured":"Ahmadi N.; Safari S.; Mirazi N.; Karimi S.A.; Komaki A.; Effects of vanillic acid on A\u03b21-40-induced oxidative stress and learning and memory deficit in male rats. Brain Res Bull 2021,170,264-273","journal-title":"Brain Res Bull"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"8239642","DOI":"10.1155\/2019\/8239642","volume":"2019","author":"Wan T.","year":"2019","unstructured":"Wan T.; Wang Z.; Luo Y.; Zhang Y.; He W.; Mei Y.; Xue J.; Li M.; Pan H.; Li W.; Wang Q.; Huang Y.; FA-97, a new synthetic caffeic acid phenethyl ester derivative, protects against oxidative stress-mediated neuronal cell apoptosis and scopolamine-induced cognitive impairment by activating Nrf2\/HO-1 signaling. Oxid Med Cell Longev 2019,2019,8239642","journal-title":"Oxid Med Cell Longev"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"Selkoe D.J.","year":"2016","unstructured":"Selkoe D.J.; Hardy J.; The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 2016,8(6),595-608","journal-title":"EMBO Mol Med"},{"key":"ref=45","first-page":"169","volume":"45","author":"Yang Y.","year":"2020","unstructured":"Yang Y.; Zhou J.; Li J.; Regulation of exosome for Alzheimer\u2019s disease derived from mesenchymal stem cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2020,45(2),169-175","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.metabol.2017.01.014","volume":"69","author":"VanItallie T.B.","year":"2017","unstructured":"VanItallie T.B.; Alzheimer\u2019s disease: Innate immunity gone awry? Metabolism 2017,69,S41-S49","journal-title":"Metabolism"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"Singh A.","year":"2019","unstructured":"Singh A.; Kukreti R.; Saso L.; Kukreti S.; Oxidative stress: A key modulator in neurodegenerative diseases. Molecules 2019,24(8),1583","journal-title":"Molecules"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"8983752","DOI":"10.1155\/2019\/8983752","volume":"2019","author":"Kong D.","year":"2019","unstructured":"Kong D.; Yan Y.; He X.Y.; Yang H.; Liang B.; Wang J.; He Y.; Ding Y.; Yu H.; Effects of resveratrol on the mechanisms of anti-oxidants and estrogen in Alzheimer\u2019s disease. BioMed Res Int 2019,2019,8983752","journal-title":"BioMed Res Int"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-90-481-8622-8_2","volume":"51","author":"Harris J.R.","year":"2010","unstructured":"Harris J.R.; Milton N.G.N.; Cholesterol in Alzheimer\u2019s disease and other amyloidogenic disorders. Subcell Biochem 2010,51,47-75","journal-title":"Subcell Biochem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/sjpain-2019-0138","volume":"20","author":"Malcangio M.","year":"2019","unstructured":"Malcangio M.; Role of the immune system in neuropathic pain. Scand J Pain 2019,20(1),33-37","journal-title":"Scand J Pain"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14728222.2020.1738391","volume":"24","author":"Anwar S.","year":"2020","unstructured":"Anwar S.; Rivest S.; Alzheimer\u2019s disease: Microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opin Ther Targets 2020,24(4),331-344","journal-title":"Expert Opin Ther Targets"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3390\/nu6041701","volume":"6","author":"Wurtman R.","year":"2014","unstructured":"Wurtman R.; A nutrient combination that can affect synapse formation. Nutrients 2014,6(4),1701-1710","journal-title":"Nutrients"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"Minter M.R.","year":"2016","unstructured":"Minter M.R.; Taylor J.M.; Crack P.J.; The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease. J Neurochem 2016,136(3),457-474","journal-title":"J Neurochem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"Kwon H.S.","year":"2020","unstructured":"Kwon H.S.; Koh S.H.; Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Transl Neurodegener 2020,9(1),42","journal-title":"Transl Neurodegener"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1248\/bpb.27.120","volume":"27","author":"Kim H.S.","year":"2004","unstructured":"Kim H.S.; Cho J.; Kim D.H.; Yan J.J.; Lee H.K.; Suh H.W.; Song D.K.; Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Biol Pharm Bull 2004,27(1),120-121","journal-title":"Biol Pharm Bull"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","volume":"1670","author":"Pepeu G.","year":"2017","unstructured":"Pepeu G.; Grazia Giovannini M.; The fate of the brain cholinergic neurons in neurodegenerative diseases. Brain Res 2017,1670,173-184","journal-title":"Brain Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/nu9080815","volume":"9","author":"Blusztajn J.","year":"2017","unstructured":"Blusztajn J.; Slack B.; Mellott T.; Neuroprotective actions of dietary choline. Nutrients 2017,9(8),815","journal-title":"Nutrients"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/ars.2007.1511","volume":"9","author":"Okouchi M.","year":"2007","unstructured":"Okouchi M.; Ekshyyan O.; Maracine M.; Aw T.Y.; Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 2007,9(8),1059-1096","journal-title":"Antioxid Redox Signal"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/03009734.2014.962714","volume":"119","author":"Wang X.","year":"2014","unstructured":"Wang X.; Welsh N.; Bcl-2 maintains the mitochondrial membrane potential, but fails to affect production of reactive oxygen species and endoplasmic reticulum stress, in sodium palmitate-induced \u03b2-cell death. Ups J Med Sci 2014,119(4),306-315","journal-title":"Ups J Med Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"26494","DOI":"10.1074\/jbc.M110.143164","volume":"285","author":"Hawkins B.J.","year":"2010","unstructured":"Hawkins B.J.; Levin M.D.; Doonan P.J.; Petrenko N.B.; Davis C.W.; Patel V.V.; Madesh M.; Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss. J Biol Chem 2010,285(34),26494-26505","journal-title":"J Biol Chem"},{"key":"ref=61","first-page":"264","volume":"39","author":"Erdal M.E.","year":"2020","unstructured":"Erdal M.E.; G\u00f6r\u00fcc\u00fc Yilmaz S.; Ay M.E.; G\u00fcler Kara H.; Avci \u00d6zge A.; Tasdelen B.; A study investigating the role of 2 candidate SNPs in Bax and Bcl-2 genes in Alzheimer\u2019s disease. P R Health Sci J 2020,39(3),264-269","journal-title":"P R Health Sci J"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.toxlet.2021.12.021","volume":"357","author":"Tianji L.","year":"2022","unstructured":"Tianji L.; Dingbang H.; Xiao C.; Xiaojing M.; Fei Z.; Bin W.; Methylmercury induces lysosomal membrane permeabilization through JNK-activated Bax lysosomal translocation in neuronal cells. Toxicol Lett 2022,357,73-83","journal-title":"Toxicol Lett"},{"key":"ref=63","first-page":"762","volume":"29","author":"Yue W.","year":"2017","unstructured":"Yue W.; Xu W.; Song Y.; Chun W.; Effects of ferulic acid on oxidative stress and apoptosis related proteins in Alzheimer\u2019s disease transgenic mice. Nat Prod Res Dev 2017,29,762-766","journal-title":"Nat Prod Res Dev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220906110506","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208581\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220906110506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T12:17:49Z","timestamp":1693657069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208581\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":63,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220906110506","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}